share_log

Cellectis Analyst Ratings

Cellectis Analyst Ratings

Cellectis 分析師評級
Benzinga ·  2023/08/07 08:57
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/07/2023 224.32% JMP Securities → $6 Reiterates Market Outperform → Market Outperform
04/05/2023 764.86% Citigroup $24 → $16 Maintains Buy
03/13/2023 602.7% Oppenheimer $16 → $13 Maintains Outperform
03/13/2023 224.32% JMP Securities → $6 Reiterates → Market Outperform
01/19/2023 224.32% JMP Securities $11 → $6 Maintains Market Outperform
05/24/2022 8.11% Goldman Sachs $3 → $2 Maintains Sell
05/18/2022 Baird Upgrades Neutral → Outperform
05/13/2022 278.38% Barclays $9 → $7 Maintains Overweight
01/06/2022 764.86% Wells Fargo → $16 Downgrades Overweight → Equal-Weight
11/30/2021 981.08% JMP Securities → $20 Initiates Coverage On → Market Outperform
10/08/2021 440.54% Baird $39 → $10 Downgrades Outperform → Neutral
04/28/2021 Guggenheim Downgrades Buy → Neutral
03/16/2021 2008.11% Baird $23 → $39 Upgrades Neutral → Outperform
10/15/2020 Baird Downgrades Outperform → Neutral
08/19/2020 1629.73% Citigroup $15 → $32 Upgrades Neutral → Buy
07/07/2020 1035.14% Baird $28 → $21 Maintains Outperform
03/06/2020 494.59% Goldman Sachs $15 → $11 Downgrades Neutral → Sell
02/19/2020 2008.11% BTIG $37 → $39 Maintains Buy
08/09/2019 BTIG Initiates Coverage On → Buy
05/24/2019 Citigroup Assumes → Neutral
03/14/2019 William Blair Initiates Coverage On → Outperform
12/19/2018 1251.35% Goldman Sachs → $25 Initiates Coverage On → Neutral
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
08/07/2023 224.32% JMP證券 →$6 重申 市場表現優於→市場表現
04/05/2023 764.86% 花旗集團 $24→$16 維護
03/13/2023 602.7% 奧本海默 $16→$13 維護 跑贏大盤
03/13/2023 224.32% JMP證券 →$6 重申 →市場跑贏大盤
2023年1月19日 224.32% JMP證券 $11→$6 維護 市場表現強於大盤
2022年05月24日 8.11% 高盛 $3→$2 維護
2022/05/18 - 貝爾德 升級 中性→表現優異
2022年05月13日 278.38% 巴克萊 $9→$7 維護 超重
01/06/2022 764.86% 富國銀行 →$16 評級下調 超重→等重
2021年11月30日 981.08% JMP證券 →$20 開始承保 →市場跑贏大盤
10/08/2021 440.54% 貝爾德 $39→$10 評級下調 跑贏→中性
04/28/2021 - 古根海姆 評級下調 購買→中性
03/16/2021 2008.11% 貝爾德 $23→$39 升級 中性→表現優異
10/15/2020 - 貝爾德 評級下調 跑贏→中性
2020年08月19日 1629.73% 花旗集團 $15→$32 升級 中性→購買
07/07/2020 1035.14% 貝爾德 $28→$21 維護 跑贏大盤
03/06/2020 494.59% 高盛 $15→$11 評級下調 中性→銷售
02/19/2020 2008.11% BTIG $37→$39 維護
2019年08月09日 - BTIG 開始承保 →購買
2019年05月24日 - 花旗集團 假設 →中性
2019/03/14 - 威廉·布萊爾 開始承保 →跑贏大盤
2018年12月19日 1251.35% 高盛 →$25 開始承保 →中性

What is the target price for Cellectis (CLLS)?

Cellectis(CLLS)的目標價是多少?

The latest price target for Cellectis (NASDAQ: CLLS) was reported by JMP Securities on August 7, 2023. The analyst firm set a price target for $6.00 expecting CLLS to rise to within 12 months (a possible 224.32% upside). 5 analyst firms have reported ratings in the last year.

納斯達克(JMP Securities)於2023年8月7日報告了Cellectis(JMP Securities:CLLS)的最新目標價。這家分析公司將目標價定為6美元,預計CLL將在12個月內升至(可能上漲224.32%)。去年有5家分析公司公佈了評級。

What is the most recent analyst rating for Cellectis (CLLS)?

Cellectis(CLLS)的最新分析師評級是多少?

The latest analyst rating for Cellectis (NASDAQ: CLLS) was provided by JMP Securities, and Cellectis reiterated their market outperform rating.

納斯達克(JMP Securities)對Cellectis的最新分析師評級為CLLS,Cellectis重申了其表現優於大盤的評級。

When is the next analyst rating going to be posted or updated for Cellectis (CLLS)?

Cellectis(CLLS)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cellectis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cellectis was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Cellectis的高管和客戶交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Cellectis的上一次評級是在2023年8月7日提交的,所以你應該預計下一次評級將在2024年8月7日左右的某個時候提供。

Is the Analyst Rating Cellectis (CLLS) correct?

分析師評級Cellectis(CLLS)正確嗎?

While ratings are subjective and will change, the latest Cellectis (CLLS) rating was a reiterated with a price target of $0.00 to $6.00. The current price Cellectis (CLLS) is trading at is $1.85, which is within the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的Cellectis(CLLS)評級被重申,目標價在0.00美元至6.00美元之間。Cellectis(CLLS)目前的交易價格為1.85美元,在分析師的預測範圍內。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論